本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

20.04
+0.01000.05%
盘后19.65-0.3900-1.95%18:13 EST
成交量:27.01万
成交额:538.63万
市值:22.24亿
市盈率:-10.42
高:20.13
开:19.85
低:19.50
收:20.03
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:0.42
换手率:0.25%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
净资产收益率:-28.97%
总资产收益率:-13.29%
市净率:2.93
市盈率(LYR):-7.71

数据加载中...

2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/16

重要事件披露

Form 8-K - Current report
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report